Kerrie Patricia Nelson, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Observer Variation | 11 | 2021 | 2593 | 2.420 |
Why?
|
Diagnostic Tests, Routine | 5 | 2021 | 783 | 1.690 |
Why?
|
Mammography | 11 | 2021 | 2476 | 1.620 |
Why?
|
Models, Statistical | 8 | 2019 | 5102 | 1.120 |
Why?
|
Gynecological Examination | 2 | 2018 | 33 | 0.790 |
Why?
|
Biostatistics | 3 | 2017 | 162 | 0.760 |
Why?
|
Breast Neoplasms | 12 | 2022 | 20822 | 0.650 |
Why?
|
Biometry | 2 | 2018 | 558 | 0.550 |
Why?
|
Mass Screening | 5 | 2019 | 5255 | 0.530 |
Why?
|
Catheterization, Peripheral | 1 | 2018 | 345 | 0.510 |
Why?
|
Emergency Service, Hospital | 16 | 2023 | 7659 | 0.490 |
Why?
|
Catheterization, Central Venous | 1 | 2018 | 514 | 0.470 |
Why?
|
Linear Models | 6 | 2019 | 5952 | 0.430 |
Why?
|
Cluster Analysis | 1 | 2019 | 2715 | 0.410 |
Why?
|
Computer Simulation | 8 | 2022 | 6196 | 0.400 |
Why?
|
Ultrasonography, Interventional | 1 | 2018 | 1486 | 0.370 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1257 | 0.370 |
Why?
|
Bayes Theorem | 4 | 2021 | 2309 | 0.330 |
Why?
|
Uterine Hemorrhage | 2 | 2018 | 255 | 0.280 |
Why?
|
Emergency Medical Services | 3 | 2022 | 1917 | 0.260 |
Why?
|
Reproducibility of Results | 6 | 2022 | 19905 | 0.260 |
Why?
|
Data Interpretation, Statistical | 4 | 2019 | 2716 | 0.250 |
Why?
|
Longitudinal Studies | 3 | 2019 | 13989 | 0.240 |
Why?
|
Drug-Seeking Behavior | 2 | 2015 | 48 | 0.240 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3507 | 0.220 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2020 | 0.220 |
Why?
|
Likelihood Functions | 1 | 2006 | 1005 | 0.220 |
Why?
|
Ultrasonography | 4 | 2020 | 5985 | 0.210 |
Why?
|
Restraint, Physical | 1 | 2023 | 193 | 0.210 |
Why?
|
Abdominal Pain | 2 | 2018 | 1063 | 0.200 |
Why?
|
Monte Carlo Method | 3 | 2022 | 1254 | 0.190 |
Why?
|
Markov Chains | 2 | 2017 | 969 | 0.170 |
Why?
|
Female | 33 | 2023 | 380194 | 0.170 |
Why?
|
Endpoint Determination | 1 | 2022 | 601 | 0.170 |
Why?
|
Mental Competency | 1 | 2020 | 176 | 0.160 |
Why?
|
Opioid-Related Disorders | 3 | 2022 | 2065 | 0.160 |
Why?
|
Etomidate | 1 | 2020 | 190 | 0.160 |
Why?
|
Patients' Rooms | 1 | 2018 | 63 | 0.160 |
Why?
|
Renal Colic | 1 | 2017 | 31 | 0.150 |
Why?
|
Humans | 41 | 2023 | 744343 | 0.140 |
Why?
|
Crowding | 1 | 2018 | 145 | 0.140 |
Why?
|
Treatment Refusal | 1 | 2020 | 421 | 0.140 |
Why?
|
Abscess | 1 | 2020 | 607 | 0.140 |
Why?
|
Ureteral Calculi | 1 | 2017 | 110 | 0.140 |
Why?
|
Hydronephrosis | 1 | 2017 | 269 | 0.130 |
Why?
|
Prostatic Neoplasms | 2 | 2016 | 11124 | 0.130 |
Why?
|
Periodontal Diseases | 1 | 2019 | 449 | 0.130 |
Why?
|
Computer Graphics | 1 | 2017 | 361 | 0.130 |
Why?
|
Logistic Models | 3 | 2019 | 13408 | 0.130 |
Why?
|
Analgesics, Opioid | 4 | 2016 | 3674 | 0.130 |
Why?
|
Adipokines | 1 | 2017 | 319 | 0.130 |
Why?
|
Ketamine | 1 | 2020 | 500 | 0.120 |
Why?
|
Dietary Fiber | 1 | 2018 | 760 | 0.120 |
Why?
|
Patient Readmission | 2 | 2018 | 3114 | 0.120 |
Why?
|
Trauma Centers | 1 | 2018 | 890 | 0.110 |
Why?
|
Naloxone | 1 | 2015 | 367 | 0.110 |
Why?
|
Heart Arrest | 1 | 2022 | 1470 | 0.100 |
Why?
|
Adiponectin | 2 | 2017 | 1100 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12245 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1065 | 0.100 |
Why?
|
Triage | 1 | 2018 | 976 | 0.100 |
Why?
|
Caloric Restriction | 1 | 2013 | 302 | 0.100 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2013 | 262 | 0.090 |
Why?
|
Chest Pain | 1 | 2018 | 1114 | 0.090 |
Why?
|
Length of Stay | 3 | 2018 | 6309 | 0.090 |
Why?
|
Emergency Medicine | 1 | 2020 | 1207 | 0.090 |
Why?
|
Narcotic Antagonists | 1 | 2015 | 562 | 0.090 |
Why?
|
Behavior, Addictive | 1 | 2016 | 462 | 0.090 |
Why?
|
Colonoscopy | 1 | 2018 | 1367 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2016 | 1101 | 0.090 |
Why?
|
ROC Curve | 1 | 2017 | 3527 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2023 | 14722 | 0.090 |
Why?
|
Emergencies | 1 | 2016 | 1170 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 638 | 0.080 |
Why?
|
Patient Transfer | 1 | 2016 | 761 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1380 | 0.080 |
Why?
|
Health Education | 1 | 2015 | 1056 | 0.080 |
Why?
|
Male | 20 | 2023 | 350118 | 0.080 |
Why?
|
Prospective Studies | 11 | 2020 | 53288 | 0.080 |
Why?
|
Retrospective Studies | 10 | 2023 | 77449 | 0.070 |
Why?
|
Drug Monitoring | 1 | 2013 | 956 | 0.070 |
Why?
|
Influenza, Human | 1 | 2018 | 1479 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1814 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2023 | 3158 | 0.070 |
Why?
|
Adult | 16 | 2023 | 214055 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.070 |
Why?
|
Decision Making | 1 | 2020 | 3887 | 0.070 |
Why?
|
Poliomyelitis | 1 | 2006 | 103 | 0.060 |
Why?
|
Stochastic Processes | 1 | 2006 | 344 | 0.060 |
Why?
|
Middle Aged | 15 | 2022 | 213383 | 0.060 |
Why?
|
Menopause | 1 | 2012 | 1626 | 0.060 |
Why?
|
Atrial Fibrillation | 2 | 2012 | 5034 | 0.060 |
Why?
|
Obesity | 2 | 2017 | 12745 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2016 | 3679 | 0.050 |
Why?
|
Algorithms | 2 | 2017 | 13881 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4687 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3778 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9856 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4091 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 1364 | 0.050 |
Why?
|
Methohexital | 1 | 2020 | 17 | 0.050 |
Why?
|
Time Factors | 6 | 2018 | 40075 | 0.050 |
Why?
|
Haiti | 1 | 2022 | 553 | 0.050 |
Why?
|
Diet | 1 | 2018 | 7939 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4558 | 0.040 |
Why?
|
Pregnancy | 2 | 2018 | 29144 | 0.040 |
Why?
|
Aged | 8 | 2020 | 163280 | 0.040 |
Why?
|
Electrocardiography | 1 | 2012 | 6442 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 845 | 0.040 |
Why?
|
Poultry | 1 | 2018 | 82 | 0.040 |
Why?
|
Odds Ratio | 3 | 2017 | 9849 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13102 | 0.040 |
Why?
|
Cathartics | 1 | 2018 | 125 | 0.040 |
Why?
|
Incidence | 3 | 2017 | 20947 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.040 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2017 | 93 | 0.040 |
Why?
|
Gelatin | 1 | 2018 | 225 | 0.040 |
Why?
|
United States | 5 | 2023 | 69872 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2017 | 360 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 300 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
Checklist | 1 | 2022 | 833 | 0.030 |
Why?
|
Drainage | 1 | 2020 | 1142 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20129 | 0.030 |
Why?
|
Administration, Intranasal | 1 | 2015 | 446 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8664 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2020 | 1265 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9313 | 0.030 |
Why?
|
Drug Users | 1 | 2015 | 134 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 25043 | 0.030 |
Why?
|
Geriatrics | 1 | 2018 | 396 | 0.030 |
Why?
|
Tennessee | 1 | 2012 | 117 | 0.030 |
Why?
|
Vegetables | 1 | 2018 | 1182 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1364 | 0.030 |
Why?
|
Software | 1 | 2006 | 4443 | 0.030 |
Why?
|
Point-of-Care Systems | 1 | 2020 | 1177 | 0.020 |
Why?
|
Pennsylvania | 1 | 2012 | 613 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3508 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2013 | 1150 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2518 | 0.020 |
Why?
|
Insurance, Health | 1 | 2022 | 2494 | 0.020 |
Why?
|
Urban Population | 1 | 2018 | 2021 | 0.020 |
Why?
|
Minority Groups | 1 | 2017 | 1223 | 0.020 |
Why?
|
Young Adult | 4 | 2018 | 56430 | 0.020 |
Why?
|
Vasodilation | 1 | 2013 | 944 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2859 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1599 | 0.020 |
Why?
|
Heart Failure | 1 | 2012 | 10900 | 0.020 |
Why?
|
Anthropometry | 1 | 2013 | 1350 | 0.020 |
Why?
|
Qualitative Research | 1 | 2017 | 2682 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1653 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2012 | 12354 | 0.020 |
Why?
|
Social Support | 1 | 2017 | 2118 | 0.020 |
Why?
|
Risk Factors | 4 | 2017 | 72290 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18370 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2488 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.020 |
Why?
|
Body Composition | 1 | 2013 | 2401 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39050 | 0.010 |
Why?
|
Adolescent | 3 | 2018 | 85781 | 0.010 |
Why?
|
Hemodynamics | 1 | 2013 | 4199 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2684 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5391 | 0.010 |
Why?
|
Weight Loss | 1 | 2013 | 2622 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2013 | 3279 | 0.010 |
Why?
|
Sex Factors | 1 | 2015 | 10397 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3923 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21746 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7181 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Infant | 1 | 2022 | 35136 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6256 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
Body Mass Index | 1 | 2013 | 12720 | 0.010 |
Why?
|
Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10638 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29063 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 57776 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 40561 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168757 | 0.000 |
Why?
|